1
|
Mirzabekyan EV, Rusanova EI, Ivanov KP. [The use of autologous platelet-rich plasma in the treatment of chronic pharyngitis]. Vestn Otorinolaringol 2024; 89:52-58. [PMID: 38805464 DOI: 10.17116/otorino20248902152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2024]
Abstract
The results of a prospective open cohort study of the use of platelet-rich plasma (platelet-rich plasma - PRP) in patients with chronic pharyngitis during the exacerbation of the disease are presented. OBJECTIVE To evaluate the clinical efficacy of autologous PRP in the treatment of chronic pharyngitis. MATERIAL AND METHODS Autologous PRP was injected into the posterior pharyngeal wall as a course of endopharyngeal blockages as part of the complex therapy of chronic pharyngitis. Patients in the control group received standard therapy, without the use of autologous PRP. The effectiveness of the studied technique was evaluated by statistical analysis of the intensity of symptoms of the disease, determined by patients throughout the entire period of treatment in the patient's diary, as well as by analyzing data from mass spectrometry of microbial markers and bacteriological examination of the pharyngeal mucosa, collected at the beginning of the study and 14 days after completion of the course of therapy. CONCLUSION The use of a course of endopharyngeal blockades with autologous platelet-rich plasma as part of the complex therapy of chronic pharyngitis, according to our estimates, provides a significant effect in the form of higher rates of reduction in the severity of symptoms of the disease, a significant reduction in the number of microorganisms deviating from the reference values (by 2 times or more), a decrease in the duration of the disease compared with the control group.
Collapse
Affiliation(s)
- E V Mirzabekyan
- Petrovsky Russian Scientific Center of Surgery, Moscow, Russia
| | - E I Rusanova
- Petrovsky Russian Scientific Center of Surgery, Moscow, Russia
- Patrice Lumumba Peoples' Friendship University of Russia, Moscow, Russia
| | - K P Ivanov
- Petrovsky Russian Scientific Center of Surgery, Moscow, Russia
| |
Collapse
|
2
|
Chen YH, Luo R, Lei SS, Li B, Zhou FC, Wang HY, Chen X, He X, Wang YZ, Zhan LH, Lu TT, Su J, Yu QX, Li B, Lv GY, Chen SH. Anti-inflammatory effect of Ganluyin, a Chinese classic prescription, in chronic pharyngitis rat model. BMC Complement Med Ther 2020; 20:265. [PMID: 32859182 PMCID: PMC7456022 DOI: 10.1186/s12906-020-03057-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2020] [Accepted: 08/19/2020] [Indexed: 12/28/2022] Open
Abstract
Background Ganluyin (GLY) is a famous classical prescription with a long history of use as a treatment for inflammatory conditions such as chronic pharyngitis (CP) in many parts of China. However, it has not been developed as a modern pharmaceutic and its anti-inflammatory mechanisms remain unclear. The aim of this study was to assess the anti-inflammatory efficacy of GLY and potential mechanisms in a rat model of CP. Methods The chemical profile of GLY was analyzed by HPLC-UV. We used a mouse model of ear edema and a rat model of paw edema. Specifically, xylene was used to induce edema on the surface of one ear in mice, and carrageenan was injected subcutaneously into the right hind paws of rats to induce paw edema. The paw thickness, ear weight, and ear perfusion were measured and recorded. The CP model in rats was induced by irritating the throat with 5% ammonia and was used to evaluate the therapeutic efficacy of GLY. Levels of interleukin-6 (IL-6), interleukin-1β (IL-1β), tumor necrosis factor (TNF-α), and prostaglandin E2 (PGE2) were measured by ELISA in serum, and protein expression of cyclooxygenase-2 (COX-2) and nuclear factor kappa-B p65 (NF-κB p65) in the throat were detected by immunohistochemistry and Western blot to evaluate the anti-inflammatory mechanism of GLY. Hematological assays were also conducted. Results There were four flavonoids identified in GLY: naringin, neohesperidin, baicalin, and wogonoside. The oral administration of GLY showed a significant inhibitory effect on xylene-induced ear swelling and ear blood flow in mice and significantly ameliorated rat right hind paw edema at doses of 6.2 and 12.4 g/kg. Mechanistic studies found that the anti-inflammatory activity of GLY was related to the inhibition of pro-inflammatory cytokines such as IL-1β, IL-6, TNF-α, and PGE2 and that GLY reduced the expression of COX-2 and NF-κB p65 proteins in the throat, attenuated throat injury, and reduced inflammatory exudates. Hematological analysis showed that treatment with GLY prevented increases in white blood cell (WBC), neutrophil (NEUT), lymphocyte (LYMPH) and monocyte (MONO) levels. Conclusions These studies indicated that GLY has beneficial anti-inflammatory effects on CP and that it acts through reducing pro-inflammatory factors such as IL-1β, IL-6, TNF-α, and PGE2, as well as decreasing WBC, NEUT, LYMPH and MONO levels and decreasing the expression of COX-2 and NF-κB p65 proteins. These findings may lay the groundwork for further studies of GLY as a suitable candidate for the treatment of inflammatory diseases such as CP.
Collapse
Affiliation(s)
- Ye-Hui Chen
- Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, People's Republic of China
| | - Rong Luo
- Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, People's Republic of China
| | - Shan-Shan Lei
- Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, People's Republic of China
| | - Bing Li
- Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, People's Republic of China
| | - Fu-Chen Zhou
- Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, People's Republic of China
| | - Hui-Ying Wang
- Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, People's Republic of China
| | - Xue Chen
- Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, People's Republic of China
| | - Xinglishang He
- Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, People's Republic of China
| | - Yu-Zhi Wang
- Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, People's Republic of China
| | - Liang-Hui Zhan
- Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, People's Republic of China
| | - Ting-Ting Lu
- Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, People's Republic of China
| | - Jie Su
- Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, People's Republic of China
| | - Qiao-Xian Yu
- Zhejiang Senyu Co., Ltd, Yiwu, Zhejiang, 322099, People's Republic of China
| | - Bo Li
- Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, People's Republic of China.
| | - Gui-Yuan Lv
- Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, People's Republic of China.
| | - Su-Hong Chen
- Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, People's Republic of China.
| |
Collapse
|